369 related articles for article (PubMed ID: 33804198)
1. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.
Gammella E; Correnti M; Cairo G; Recalcati S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804198
[TBL] [Abstract][Full Text] [Related]
2. The role of cellular iron deficiency in controlling iron export.
Link C; Knopf JD; Marques O; Lemberg MK; Muckenthaler MU
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129829. PubMed ID: 33340587
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepcidin and ferroportin in full term placenta of pregnant cows.
Roperto S; Russo V; Urraro C; Cutarelli A; Perillo A; De Falco F; Roperto F
Theriogenology; 2017 Nov; 103():90-97. PubMed ID: 28780484
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
Nemeth E; Ganz T
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin-ferroportin axis in health and disease.
Ginzburg YZ
Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
[TBL] [Abstract][Full Text] [Related]
7. The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.
De Domenico I; Lo E; Yang B; Korolnek T; Hamza I; Ward DM; Kaplan J
Cell Metab; 2011 Nov; 14(5):635-46. PubMed ID: 22019085
[TBL] [Abstract][Full Text] [Related]
8. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
Elife; 2016 Nov; 5():. PubMed ID: 27897970
[TBL] [Abstract][Full Text] [Related]
9. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
[TBL] [Abstract][Full Text] [Related]
10. The iron-regulatory hormone hepcidin: a possible therapeutic target?
Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C
Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158
[TBL] [Abstract][Full Text] [Related]
11. Mice with hepcidin-resistant ferroportin accumulate iron in the retina.
Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL
FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980
[TBL] [Abstract][Full Text] [Related]
12. Ironing out Ferroportin.
Drakesmith H; Nemeth E; Ganz T
Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M
Bone; 2020 Aug; 137():115400. PubMed ID: 32380257
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin and ferroportin: the new players in iron metabolism.
De Domenico I; Ward DM; Kaplan J
Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
[TBL] [Abstract][Full Text] [Related]
15. Mice overexpressing hepcidin suggest ferroportin does not play a major role in Mn homeostasis.
Jin L; Frazer DM; Lu Y; Wilkins SJ; Ayton S; Bush A; Anderson GJ
Metallomics; 2019 May; 11(5):959-967. PubMed ID: 30888356
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the functional properties of human and mouse ferroportin.
Azucenas CR; Ruwe TA; Bonamer JP; Qiao B; Ganz T; Jormakka M; Nemeth E; Mackenzie B
Am J Physiol Cell Physiol; 2023 May; 324(5):C1110-C1118. PubMed ID: 36939203
[TBL] [Abstract][Full Text] [Related]
17. Iron and hepcidin: a story of recycling and balance.
Camaschella C
Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients.
Ambachew S; Biadgo B
Acta Haematol; 2017; 138(4):183-193. PubMed ID: 29136618
[TBL] [Abstract][Full Text] [Related]
19. Effect of ferroportin polymorphism on iron homeostasis and infection.
Kasvosve I
Clin Chim Acta; 2013 Feb; 416():20-5. PubMed ID: 23178444
[TBL] [Abstract][Full Text] [Related]
20. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
